Skip to Main Content

Paper Details

An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
Alzheimers Res Ther
33
2016
Author NameAffiliation
Abdel G ElkahlounNational Human Genome Research Institute, National Institutes of Health
  • 1 - 1

Datasets

Release 1.2